Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

Rang in Aktien #3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Aktienkurs
$32.32
Marktkapitalisierung
$5.33B
Veränderung (1 Tag)
-3.01%
Veränderung (1 Jahr)
47.99%
Land
IN
Handel Gland Pharma Limited (GLAND)

Kategorie

Healthcare
Aktien-Split-Historie für Gland Pharma Limited (GLAND)
Die Aktie Gland Pharma Limited (Symbol: GLAND) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine GLAND-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 GLAND-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber